The HIV Vaccine Research and Design (HIVRAD) Program supports multi-component, multi-disciplinary projects that investigate scientific questions related to AIDS prophylactic vaccine discovery research. The program allows for extensive evaluation of vaccine concepts in non-human primate models. The funding instrument is a grant, categorized as discretionary, and the program is administered by the U.S. Department of Health and Human Services through the National Institutes of Health (NIH).
The HIV Vaccine Research and Design (HIVRAD) Program supports multi-component, multi-disciplinary projects that investigate scientific questions related to AIDS prophylactic vaccine discovery research. The program allows for extensive evaluation of vaccine concepts in non-human primate models. The funding instrument is a grant, categorized as discretionary, and the program is administered by the U.S. Department of Health and Human Services through the National Institutes of Health (NIH).